Indeed, human astrocytes exposed to the concentration of cladribine reflecting the mean estimated brain exposure in MS patients presented unaltered survival and capacity to proliferate when cladribine function was dependent or independent on DCK phosphorylation (Figure 2a,b, Supplemental Tables S5 and S6). The gene discussed is DCK; the disease is myeloid sarcoma.